WID to Host Symposium Focused on Antimicrobial Resistance
|
|
On June 21 and 22, WID's Small World Initiative will host the Midwest’s premier conference on antimicrobial resistance (AMR) and antibiotic discovery featuring talks from world-renowned researchers and a panel of professionals who work on the front lines of the AMR crisis—from health care and sports medicine to animal medication practices.
Register at no cost and join the conversation.
|
|
Keynote Address: Dr. Aileen Rubio
Aileen Rubio, PhD, is the Head of Biology for Spero Therapeutics in Cambridge, MA. She previously held positions at Cubist Pharmaceuticals, where she worked for over 9 years. During that time, she worked on antibacterial discovery projects and provided support for business development activities. She has also collaborated with several key opinion leaders to investigate the mechanism of action/resistance of Cubicin (daptomycin for injection) in Staphylococcus aureus. Dr. Rubio received BS degrees in both Microbiology and Chemistry from the University of Illinois at Champaign-Urbana, a PhD in Bacteriology from the University of Wisconsin-Madison, and completed post-doctoral research at the University of California at San Diego.
|
|
Introduction to Smarticles Technology:
Dr. Michael Lewinski
Michael Lewinski, Ph.D., D(ABMM), CM, MB(ASCP)CM, is currently the Senior Director of Medical Affairs, Microbiology and Smarticles technology at Roche Molecular Systems, Inc. His research interests have focused on the development and the automation of molecular tests for the detection, quantification, and characterization of microorganisms for the diagnosis of disease and for monitoring disease progression and response to therapy. He holds several patents and has published in various disciplines within infectious diseases and laboratory medicine.
|
|
|
|
|
|
